日本为患有严重抑郁症的老年人提供抗抑郁药:系统性审查和元分析

相关实验视频

Updated: Jul 4, 2025

04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

1.1K

Taro Kishi¹, Kenji Sakuma¹, Masakazu Hatano²

¹Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.

Neuropsychopharmacology reports

|February 6, 2024

概括

抗抑郁药对患有主要抑郁障碍 (MDD) 的老年人来说显示出更好的反应率,但增加了不良事件. 在这种人群中,对治疗中度至重度的MDD提出了微弱的建议.

科学领域:

老年精神病学是一门精神病学专业.
药理疗法药理疗法药理疗法
临床试验分析

背景情况:

重度抑郁症 (MDD) 对老年人产生重大影响,需要更新治疗指南.
关于抗抑郁药在老年人群中的有效性和安全性的现有证据需要进行系统评估.
本综述解决了对老年人多重抑郁症治疗的基于证据的建议的需要.

研究的目的:

系统地审查和对MDD的老年人抗抑郁药物的随机对照试验 (RCT) 进行元分析.
通知日本情绪障碍学会更新的治疗指南.
评估日本可用的抗抑郁药的疗效和安全性.

主要方法:

对双盲,随机,安慰剂受控试验的系统审查和双对元分析.
包括专注于MDD的老年人抗抑郁药的研究.
结果指标:应答率,抑郁症状评分表,缓解率,停药率和不良事件.

主要成果:

分析了9个RCT (n=2145),包括杜洛西丁,埃斯基塔洛普拉姆,伊米普拉明,塞特拉林,文拉法辛和伏尔托克塞丁.
与安慰剂相比,抗抑郁药显示出显著更高的反应率和改善的抑郁症状得分.
然而,抗抑郁药与因不良事件和不良事件发生率较高而导致停药的增加有关.

结论:

在老年人中,适度至严重的MDD抗抑郁药治疗显示出有效性,但与不良事件增加有关.
这些发现支持在这个人群中使用可用的抗抑郁药的弱点建议.
需要进一步的研究,特别是在日本进行的研究,以完善治疗指南.

关键词:

在日本可用的抗抑郁药.有效性有效性有效性.患有严重抑郁症的老年人在安全方面,安全是安全的.系统审查和元分析.

相关概念视频

01:23

Antidepressant Drugs: MAOIs and Other Agents

234

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

234

01:25

Antidepressant Drugs: Overview

490

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...

490

01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

394

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...

394

01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

01:18

Depression: Overview

244

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

244

01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

176

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

176